Bay Street News, March 26th, 2020

LEXINGTON, Mass. and AMSTERDAM, March 26, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing […]

TORONTO, March 26, 2020 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX/TSX: CDV) is pleased to advise that it has received […]

MONTRÉAL, March 26, 2020 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – A conference call for analysts and institutional investors will […]

BARRIE, Ontario, March 26, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or […]

TORONTO, March 26, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM) (FSE: D4G) (OTC: DTMXF) is pleased […]

OTTAWA, March 26, 2020 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived […]

SAINT LAURENT, Quebec, March 26, 2020 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the “Company” or “IntelGenx”) today reported [...]

Partnering with The University of South Australia developers of the technology in collaboration with the Australian Department of Defence – […]

CALGARY, Alberta, March 26, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a […]

Dosing Initiated in PROPEL Phase 1/2 Trial of PR001 for Treatment of Parkinson’s Disease with GBA1 MutationsPreparations Underway to Initiate […]